BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pasquinucci L, Turnaturi R, Montenegro L, Caraci F, Chiechio S, Parenti C. Simultaneous targeting of MOR/DOR: A useful strategy for inflammatory pain modulation. Eur J Pharmacol 2019;847:97-102. [PMID: 30690004 DOI: 10.1016/j.ejphar.2019.01.031] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Liu J, Xie X, Qin K, Xu L, Peng J, Li X, Li X, Liu Z. Dexamethasone and potassium canrenoate alleviate hyperalgesia by competitively regulating IL-6/JAK2/STAT3 signaling pathway during inflammatory pain in vivo and in vitro. Immun Inflamm Dis 2022;10:e721. [PMID: 36301041 DOI: 10.1002/iid3.721] [Reference Citation Analysis]
2 Turnaturi R, Chiechio S, Pasquinucci L, Spoto S, Costanzo G, Dichiara M, Piana S, Grasso M, Amata E, Marrazzo A, Parenti C. Novel N-normetazocine Derivatives with Opioid Agonist/Sigma-1 Receptor Antagonist Profile as Potential Analgesics in Inflammatory Pain. Molecules 2022;27:5135. [PMID: 36014375 DOI: 10.3390/molecules27165135] [Reference Citation Analysis]
3 Spadaro A, Pasquinucci L, Lorenti M, Santagati LM, Sarpietro MG, Turnaturi R, Parenti C, Montenegro L. Solid Lipid Nanoparticles as Carriers for the Synthetic Opioid LP2: Characterization and In Vitro Release. Applied Sciences 2021;11:10250. [DOI: 10.3390/app112110250] [Reference Citation Analysis]
4 Fidilio A, Grasso M, Turnaturi R, Caruso G, Spitale FM, Vicario N, Parenti R, Spoto S, Musso N, Marrazzo A, Chiechio S, Caraci F, Pasquinucci L, Parenti C. The Multimodal MOPr/DOPr Agonist LP2 Reduces Allodynia in Chronic Constriction Injured Rats by Rescue of TGF-β1 Signalling. Front Pharmacol 2021;12:749365. [PMID: 34690781 DOI: 10.3389/fphar.2021.749365] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
5 Pasquinucci L, Parenti C, Georgoussi Z, Reina L, Tomarchio E, Turnaturi R. LP1 and LP2: Dual-Target MOPr/DOPr Ligands as Drug Candidates for Persistent Pain Relief. Molecules 2021;26:4168. [PMID: 34299443 DOI: 10.3390/molecules26144168] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Assenov B, Pechlivanova D, Dzhambazova E, Peneva P, Todorov P. Antinociceptive Effects of VV-Hemorphin-5 Peptide Analogues Containing Amino phosphonate Moiety in Mouse Formalin Model of Pain. Protein Pept Lett 2021;28:442-9. [PMID: 32798365 DOI: 10.2174/0929866527666200813200714] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Liu Q, Fan W, He H, Huang F. The role of peripheral opioid receptors in orofacial pain. Oral Dis 2021;27:1106-14. [PMID: 32437594 DOI: 10.1111/odi.13435] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 Pasquinucci L, Parenti C, Ruiz-Cantero MC, Georgoussi Z, Pallaki P, Cobos EJ, Amata E, Marrazzo A, Prezzavento O, Arena E, Dichiara M, Salerno L, Turnaturi R. Novel N-Substituted Benzomorphan-Based Compounds: From MOR-Agonist/DOR-Antagonist to Biased/Unbiased MOR Agonists. ACS Med Chem Lett 2020;11:678-85. [PMID: 32435370 DOI: 10.1021/acsmedchemlett.9b00549] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
9 Turnaturi R, Pasquinucci L, Chiechio S, Grasso M, Marrazzo A, Amata E, Dichiara M, Prezzavento O, Parenti C. Exploiting the Power of Stereochemistry in Drug Action: 3-[(2S,6S,11S)-8-Hydroxy-6,11-dimethyl-1,4,5,6-tetrahydro-2,6-methano-3-benzazocin-3(2H)-yl]-N-phenylpropanamide as Potent Sigma-1 Receptor Antagonist. ACS Chem Neurosci 2020;11:999-1005. [PMID: 32186844 DOI: 10.1021/acschemneuro.9b00688] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
10 Cascella M. Introductory Chapter: The Rationale for a Multimodal Approach to Pain Treatment. From Conventional to Innovative Approaches for Pain Treatment 2019. [DOI: 10.5772/intechopen.85864] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
11 Turnaturi R, Chiechio S, Salerno L, Rescifina A, Pittalà V, Cantarella G, Tomarchio E, Parenti C, Pasquinucci L. Progress in the development of more effective and safer analgesics for pain management. Eur J Med Chem 2019;183:111701. [PMID: 31550662 DOI: 10.1016/j.ejmech.2019.111701] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 7.7] [Reference Citation Analysis]
12 Vicario N, Pasquinucci L, Spitale FM, Chiechio S, Turnaturi R, Caraci F, Tibullo D, Avola R, Gulino R, Parenti R, Parenti C. Simultaneous Activation of Mu and Delta Opioid Receptors Reduces Allodynia and Astrocytic Connexin 43 in an Animal Model of Neuropathic Pain. Mol Neurobiol 2019;56:7338-54. [PMID: 31030416 DOI: 10.1007/s12035-019-1607-1] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 9.0] [Reference Citation Analysis]
13 Pasquinucci L, Turnaturi R, Calò G, Pappalardo F, Ferrari F, Russo G, Arena E, Montenegro L, Chiechio S, Prezzavento O, Parenti C. (2S)-N-2-methoxy-2-phenylethyl-6,7-benzomorphan compound (2S-LP2): Discovery of a biased mu/delta opioid receptor agonist. Eur J Med Chem 2019;168:189-98. [PMID: 30822708 DOI: 10.1016/j.ejmech.2019.02.043] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]